Canada markets open in 3 hours 8 minutes

ABIONYX Pharma SA (609.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.9950-0.0070 (-0.70%)
As of 11:42AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
4,750
5,252
675
0
Cost of Revenue
4,217
4,616
416
0
Gross Profit
533
636
259
0
Operating Expenses
Research Development
1,162
1,107
3,838
2,137
Selling General and Administrative
1,315
1,321
586
562
Total Operating Expenses
4,415
4,745
6,211
2,968
Operating Income or Loss
-3,882
-4,109
-5,952
-2,968
Interest Expense
65
61
8
0
Income Before Tax
-3,904
-4,206
-5,822
-1,886
Income Tax Expense
-
-
0
0
Income from Continuing Operations
-3,904
-4,206
-5,822
-1,886
Net Income
-3,904
-4,206
-5,822
-1,886
Net Income available to common shareholders
-3,904
-4,206
-5,822
-1,886
Basic EPS
-0.14
-0.15
-0.23
-0.08
Diluted EPS
-0.14
-0.15
-0.23
-0.08
Basic Average Shares
28,216
27,967
24,880
22,508
Diluted Average Shares
29,854
29,860
25,919
23,488